News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
siam.in Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
This page provides a financial overview of SANUWAVE Health, Inc. (SNWV), focusing on its revenue breakdown. It indicates a lack of detailed data for revenue by segment or geography, as well as an absence of recent Congressional trading, corporate lobbying, U.S. patent grants, and โฆ
This article provides a stock analysis of SANUWAVE Health (Nasdaq:SNWV), a medical device company. It highlights that the stock is trading significantly below its fair value but notes risks such as high volatility and non-cash earnings. The report also details recent financial updates, including โฆ
The article focuses on the enterprise value to EBIT forward for SANUWAVE Health, Inc. (NASDAQ: SNWV). It appears to be a financial data page from TradingView, providing an overview of the company's financial metrics. The content is primarily a listing of navigation and legal โฆ
This article provides the "Price to book forward" financial metric for SANUWAVE Health, Inc. (NASDAQ:SNWV). It appears to be a financial data point from TradingView, indicating a specific value, change, and percentage change for this metric over a certain period. The content primarily focuses โฆ
This article provides a company profile and introduction for SANUWAVE Health. It is a brief overview of the company.
Solas Capital Management, LLC and its portfolio manager Frederick Tucker Golden have reported a 7.1% beneficial ownership stake in SANUWAVE Health, Inc. (SNWV) through managed funds. This ownership amounts to 610,968 shares, held by two private funds and one sub-advised fund, granting them shared โฆ
Sanuwave Health, Inc. (NASDAQ: SNWV) reported its Q2 FY2026 financial results, with revenues down 3% year-over-year to $9.7 million and a GAAP operating loss of $(0.3) million. The company's net loss for the quarter was $0.7 million. Facing challenges in the advanced wound care โฆ
Sanuwave Health reported a wider-than-expected loss and missed revenue estimates for Q2 2026, primarily due to a sharp decline in UltraMIST system sales, despite growth in recurring applicator revenue. The company withdrew its full-year 2026 revenue guidance, citing uncertainty surrounding potential Medicare reimbursement changes โฆ
This article provides details on SANUWAVE Health, Inc.'s Q2 2026 earnings call presentation. The company published a slide deck in conjunction with the call, which is the subject of this content. The article was written by SA Transcripts, a team responsible for publishing numerous โฆ
SANUWAVE Health, Inc. reported its Q2 2026 financial results, showing a decline in revenue to $9.74M from $10.05M in the prior year and a net loss of $0.682M compared to a net income of $0.551M year-over-year. Diluted EPS also decreased from $0.06 to $(0.08). โฆ
Sanuwave Health reported Q2 2026 revenues of $9.7 million, a 3% decline from Q2 2025, resulting in a net loss of $0.7 million. The company has withdrawn its fiscal year 2026 guidance due to uncertainties surrounding Medicare reimbursement changes, particularly the proposed rule for โฆ
Opaleye Management Inc., Opaleye, L.P., and James Silverman have reported a beneficial ownership of 3.60% in SANUWAVE Health, Inc., totaling 309,948 shares. This stake is below the 5% threshold, as indicated in their amended Schedule 13G filing. The reported ownership is based on 8,598,976 โฆ
SANUWAVE Health, Inc. (NASDAQ: SNWV) generated $44.05 million USD in revenue last year. The largest portion, $25.80 million USD, came from its Consumable, Parts, and Accessories segment, an increase from the previous year. The United States was the primary contributor to this revenue, accounting โฆ
EDEN PRAIRIE, Minn., July 30, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwaveโ) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, August 7, 2026, at 8:30 AM (ET) to present โฆ
Search by ticker symbol or company name and select a result to open its chart.
Start typing to find a stock or ETF.
Choose one or more countries for market search, or include every covered market.
Currently searching United States